BAIN CAPITAL PUBLIC EQUITY MANAGEMENT II, LLC – BioCryst Pharmaceuticals, Inc. Transaction History
BAIN CAPITAL PUBLIC EQUITY MANAGEMENT II, LLC portfolio value:
$0
portfolio value
BAIN CAPITAL PUBLIC EQUITY MANAGEMENT II, LLC quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -224.76K shares | -2.37M | $12.6 | 0 |
| Q2 2022 | share | Decrease | -56.79% | -295.43K shares | -6.08M | $10.58 | 224.76K |
| Q1 2022 | share | Decrease | -63.56% | -907.17K shares | -11.31M | $16.26 | 520.19K |
| Q4 2021 | share | Decrease | -3.06% | -45.09K shares | -1.39M | $13.79 | 1.42M |
| Q4 2021 | call | Decrease | -100.00% | -200K shares | -2.87M | $13.79 | 0 |
| Q3 2021 | call | Increase | +7900.00% | 197.5K shares | 2.48M | $14.37 | 200K |
| Q3 2021 | share | Decrease | -5.65% | -88.25K shares | -3.51M | $14.37 | 1.47M |
| Q2 2021 | call | Increase | 0.00% | 2.5K shares | 388K | $15.81 | 2.5K |
| Q2 2021 | share | Increase | +117.15% | 842K shares | 17.36M | $15.81 | 1.56M |
| Q1 2021 | share | Increase | 0.00% | 718.73K shares | 7.30M | $10.17 | 718.73K |